The authors examined three different groups, each comprising 15 middle-aged overweight to obese males: impaired glucose tolerance, type 2 diabetes on oral glucose-lowering agents and type 2 diabetes on insulin. The gene discussed is INS; the disease is type 2 diabetes mellitus.